News Author: Sharon Worcester Publish date: April 29, 2020
Talazoparib did not confer an overall survival benefit over chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advan...
News Author: Sharon Worcester Publish date: April 28, 2020
A comprehensive supportive program may improve quality of life and reduce treatment interruptions in cancer patients experiencing treatment-related...
News Author: Sharon Worcester Publish date: April 22, 2020
Ibrutinib (Imbruvica) earns expanded indication for combination with rituximab as frontline treatment for adult CLL and SLL.
News Author: Sharon Worcester Publish date: April 21, 2020
Lung cancer patients should be tested for COVID-19 “at the earliest opportunity and as a very high priority,” edi...
News Author: Sharon Worcester Publish date: April 21, 2020
The pathophysiological mechanism of HAPE is a “fundamentally different phenomenon” than what is seen in COVID-19–related ARDS, experts noted in a r...
News Author: Sharon Worcester Publish date: April 20, 2020
ORLANDO – Treatment with pepinemab/avelumab produced disease control rates of 59% in immunotherapy-resistant patients and 81% in immunotherapy-naiv...
News Author: Sharon Worcester Publish date: April 20, 2020
“It is vital that mothers who are at increased risk for CVD or have established CVD be referred to a cardiologist for cardiovascular assessment and...
News Author: Sharon Worcester Publish date: April 17, 2020
Longer follow-up has revealed improvements in progression-free and overall survival when trastuzumab is added to carboplatin and paclitaxel.
News Author: Sharon Worcester Publish date: April 15, 2020
A significant compensation discrepancy exists between male and female gynecologic oncologists, a rec...
News Author: Sharon Worcester Publish date: April 15, 2020
“Metformin now joins beta-blockers, statins, and immunonutrition as preoperative agents associated with improved surgical outcomes.”
Article Author: Sharon Worcester Publish date: April 9, 2020
An international group has devised a plan for preventing the spread of infection, treating COVID-19, and adjusting cancer treatments.
News Author: Sharon Worcester Publish date: April 9, 2020
Apatinib plus camrelizumab produced responses regardless of PD-L1 expression.
News Author: Sharon Worcester Publish date: April 7, 2020
A weight loss intervention was unsuccessful in obese endometrial cancer survivors.
News Author: Sharon Worcester Publish date: April 6, 2020
“This is a kind of disease in which you don’t have to follow the protocol – you have to follow the physiology. Unfortunately, many, many doctors ar...
News Author: Sharon Worcester Publish date: March 24, 2020
But a WHO expert said the organization needs to look into whether anosmia is an early sign and symptom.